Rezolute SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

SCHEDULE 13GOct. 28, 2026, 3:44 p.m. ETView on SEC.gov
4Oct. 23, 2026, 4:52 p.m. ETView on SEC.gov
8-KOct. 14, 2026, 5:11 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KOct. 5, 2026, 8 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedRezolute Says FDA Recommends Pre-BLA Meeting for Congenital HI Drug Ersodetug Despite Failed sunRIZE Primary Endpoint
10-KSept. 24, 2026, 4:24 p.m. ETView on SEC.gov
8-KSept. 24, 2026, 4:16 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4Sept. 3, 2026, 4:42 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 6:08 a.m. ETView on SEC.gov
SCHEDULE 13GAug. 12, 2026, 11:05 a.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 12, 2026, 12:26 p.m. ETView on SEC.gov